Corpus Intelligence IC Memo — BMH - CALHOUN 2026-04-26 09:56 UTC
IC Memo — BMH - CALHOUN
Investment Committee Memorandum | MS | 25 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BMH - CALHOUN

CCN 251331 | CALHOUN, MS | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BMH - CALHOUN is a 25-bed rural/critical access in CALHOUN, MS with $20.9M in net patient revenue and a -11.5% operating margin. The hospital serves a payer mix of 89.2% Medicare, 0.7% Medicaid, and 10.1% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.5% to -4.1% (+736bps).

Net Revenue HCRIS$20.9M
Current EBITDA COMPUTED$-2.4M
Operating Margin COMPUTED-11.5%
Occupancy HCRIS41.3%
Revenue / Bed COMPUTED$834K
Net-to-Gross HCRIS62.4%
Distress Probability ML55.8%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
69
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -11.5% places it above the state median. Among 69 size-comparable peers (12-50 beds), the median margin is -14.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 69 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BMH - CALHOUN (Target)MS25$20.9M-11.5%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
UMMC-GRENADAMS49$63.7M7.1%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
MONROE REGIONAL HOSPITALMS25$45.6M0.9%
CLAY COUNTY MEDICAL CORPORATIOMS49$45.4M0.5%
HIGHLAND COMMUNITY HOSPITALMS49$42.4M-27.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$438K+210bp18mo
Cost to Collect4.5%2.5%$417K+200bp12mo
Denial Rate Reduction12.0%6.5%$413K+198bp12mo
A/R Days Reduction5200.0%3800.0%$254K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$438K
Cost to Collect
$417K
Denial Rate Reduction
$413K
A/R Days Reduction
$254K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-2.4M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$-864K
Current Margin-11.5%
Pro Forma Margin-4.1%
WC Released (1x)$800K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.7M$-473K0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.7M$-1.7M0.00x-100.0%
Bull Case9.0x11.0x$-3.3M$2.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.3M$1.4M0.00x-100.0%
Bear Case11.0x10.0x$-4.1M$-6.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.1M$-9.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 89.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 55.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 69 hospitals with 12-50 beds
  • Same-state prioritization (n=70)
  • Comp margins: P25=-25.8% / P50=-14.9% / P75=-5.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.